COVID-19 and MAFLD/NAFLD: An updated review

A Nowroozi, S Momtazmanesh, N Rezaei - Frontiers in Medicine, 2023 - frontiersin.org
The COVID-19 pandemic is ongoing and places a substantial burden on healthcare systems
worldwide. As we further shed light on different disease characteristics, we identify more and …

[HTML][HTML] Clinical implications of COVID-19 in patients with metabolic-associated fatty liver disease

MS Jeeyavudeen, R Chaudhari… - World Journal of …, 2023 - ncbi.nlm.nih.gov
People across the world are affected by the" coronavirus disease 2019 (COVID-19)",
brought on by the" SARS-CoV type-2 coronavirus". Due to its high incidence in individuals …

Exploring Paxlovid Efficacy in COVID-19 Patients with MAFLD: Insights from a Single-Center Prospective Cohort Study

M Buchynskyi, V Oksenych, I Kamyshna, O Kamyshnyi - Viruses, 2024 - mdpi.com
This study investigates the intricate interplay between Metabolic-associated Fatty Liver
Disease (MAFLD) and COVID-19, exploring the impact of MAFLD on disease severity …

TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD—A Prospective Case–Control Study

F Susak, N Vrsaljko, A Vince, N Papic - Microorganisms, 2023 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD), the leading cause of chronic liver disease in
Western countries, has been identified as a possible risk factor for COVID-19 severity …

COVID-19 and fatty liver disorders

M Guarino, V Cossiga, FM Cutolo… - Journal of Clinical …, 2023 - mdpi.com
In late 2019, the world was shaken by the COVID-19 pandemic. Severe Acute Respiratory
Syndrome Coronavirus—2 (SARS-CoV-2) infection became one of the main causes of …

Steatotic Liver Disease and Sepsis Outcomes—A Prospective Cohort Study (SepsisFAT)

J Krznaric, N Papic, N Vrsaljko, B Gjurasin… - Journal of Clinical …, 2024 - mdpi.com
Background: While it has been shown that steatotic liver disease (SLD) is associated with
systemic changes in immune response, the impact of SLD on sepsis outcomes has not yet …

High plasma interleukin‐6 level, but not IL‐6 gene variants, as a predictive marker for the development of hepatocellular carcinoma in a Moroccan population

IA Tanouti, H Fellah, A Haddaji, C Zerrad… - International Journal …, 2024 - Wiley Online Library
Chronic inflammation triggered by hepatitis B (HBV) and hepatitis C (HCV) viruses elevates
interleukin 6 (IL‐6) levels, activating pathways that cause liver damage and contribute to …

[HTML][HTML] Immunophenotyping to improve the mechanistic understanding of idiosyncratic drug-induced liver injury: clinical implications and future directions

A Cueto-Sánchez, DE Di Zeo-Sánchez… - Exploration of …, 2023 - explorationpub.com
The late event onset of a fraction of idiosyncratic drug-induced liver injury (DILI) cases and
the link observed by genome-wide association studies (GWASs) of certain human leucocyte …

Metabolic Associated Fatty Liver Disease (MAFLD) and COVID-19 Infection: An Independent Predictor of Poor Disease Outcome?

V Milivojević, J Bogdanović, I Babić, N Todorović… - Medicina, 2023 - mdpi.com
Background and Objectives: Early reports on COVID-19 infection suggested that the SARS-
CoV-2 virus solely attacks respiratory tract cells. As the pandemic spread, it became clear …

[HTML][HTML] Immunological Insights on Pathogenic Connections between Hepato-Digestive Disorders and Periodontal Conditions

DM Popescu, DN Gheorghe, F Nicolae… - Chemokines …, 2022 - intechopen.com
The oral cavity is an integral part of the digestive tract and thus significant diseases,
including periodontitis, can have an important impact on the normal nutritional functions of …